Stoke Therapeutics (STOK) Return on Capital Employed Growth (3y) (2022 - 2026)
Stoke Therapeutics (STOK) Return on Capital Employed Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -3,782.00 |
| 10 | Stoke Therapeutics | 1.86 Bn | 1.52 Bn | - | -358.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -358.00 |
| Dec 31, 2025 | 3,811.00 |
| Sep 30, 2025 | 4,723.00 |
| Jun 30, 2025 | 4,588.00 |
| Mar 31, 2025 | 4,993.00 |
| Dec 31, 2024 | -427.00 |
| Sep 30, 2024 | -1,600.00 |
| Jun 30, 2024 | -2,855.00 |
| Mar 31, 2024 | -4,479.00 |
| Dec 31, 2023 | -3,412.00 |
| Sep 30, 2023 | -2,537.00 |
| Jun 30, 2023 | -2,359.00 |
| Mar 31, 2023 | -2,518.00 |
| Dec 31, 2022 | -2,879.00 |
| Sep 30, 2022 | -2,674.00 |